FR8172M - - Google Patents

Info

Publication number
FR8172M
FR8172M FR163498A FR163498A FR8172M FR 8172 M FR8172 M FR 8172M FR 163498 A FR163498 A FR 163498A FR 163498 A FR163498 A FR 163498A FR 8172 M FR8172 M FR 8172M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR163498A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR8172M publication Critical patent/FR8172M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/32Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR163498A 1967-08-21 1968-08-20 Expired FR8172M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38493/67A GB1241656A (en) 1967-08-21 1967-08-21 Improvements in or relating to cephalosporin compounds

Publications (1)

Publication Number Publication Date
FR8172M true FR8172M (fr) 1970-08-31

Family

ID=10403828

Family Applications (2)

Application Number Title Priority Date Filing Date
FR163498A Expired FR8172M (fr) 1967-08-21 1968-08-20
FR1588246D Expired FR1588246A (fr) 1967-08-21 1968-08-20

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR1588246D Expired FR1588246A (fr) 1967-08-21 1968-08-20

Country Status (14)

Country Link
US (2) US3665003A (fr)
JP (1) JPS5010873B1 (fr)
AT (2) AT306240B (fr)
BE (1) BE719710A (fr)
CA (1) CA946381A (fr)
CH (2) CH571528A5 (fr)
DE (2) DE1795188C3 (fr)
ES (1) ES357409A1 (fr)
FR (2) FR8172M (fr)
GB (1) GB1241656A (fr)
IE (1) IE32291B1 (fr)
IL (1) IL30580A (fr)
NL (1) NL159668B (fr)
SE (1) SE386182B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS502518B1 (fr) * 1970-12-24 1975-01-27
CH591500A5 (fr) * 1972-06-29 1977-09-30 Ciba Geigy Ag
US3917587A (en) * 1972-11-28 1975-11-04 Lilly Co Eli Cephalosporin ethers
US3917588A (en) * 1972-11-28 1975-11-04 Lilly Co Eli {60 -Aminoacyl cephalosporin ethers
GB1476981A (en) * 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
US4008231A (en) * 1975-09-15 1977-02-15 Eli Lilly And Company Preparation of 3-methoxymethylcephalosporins
FI771866A (fr) * 1976-06-28 1977-12-29 Fujisawa Pharmaceutical Co
US4409215A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical Co., Ltd. 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof
JPS5896091A (ja) * 1981-12-01 1983-06-07 Sankyo Co Ltd 3−アルコキシメチルセフアロスポリン類の製造法
AT384222B (de) * 1985-06-03 1987-10-12 Biochemie Gmbh Verfahren zur herstellung von 7-amino-3alkoxymethyl-3-cephem-4-carbonsaeuren
JPS6260212U (fr) * 1985-06-28 1987-04-14
DE3789412T2 (de) * 1986-10-02 1994-06-30 Asahi Chemical Ind Verfahren zur Herstellung von 3-Alkoxymethylcephalosporinen.
JPH01157988A (ja) * 1987-12-12 1989-06-21 Microbial Chem Res Found 経口用セフアロスポリン優導体
JP2612493B2 (ja) * 1988-05-24 1997-05-21 旭化成工業株式会社 3―置換メチル―3―セフェム―4―カルボン酸類の製造方法
AT401177B (de) * 1993-10-22 1996-07-25 Biochemie Gmbh Verfahren zur herstellung von 7-amino-3-cephem-4-carbonsäure-derivaten
US5604222A (en) * 1993-12-27 1997-02-18 Lupin Laboratories, Ltd. Method for the preparation of 2-chloro sulfinyl azetidinones
US5578721A (en) * 1994-07-11 1996-11-26 Lupin Laboratories Limited Process for preparation of 3-exomethylene cepham sulfoxide esters
WO2017153824A1 (fr) 2016-03-07 2017-09-14 Dhanuka Laboratories Ltd. Procédé d'alkylation du groupe hydroxyméthyle en position -3 des céphalosporines
GB201818410D0 (en) * 2018-11-12 2018-12-26 Imperial Innovations Ltd Compounds

Also Published As

Publication number Publication date
ES357409A1 (es) 1970-03-01
DE1795188A1 (de) 1972-03-16
DE1795717A1 (de) 1974-02-28
NL6811830A (fr) 1969-02-25
DE1795188C3 (de) 1979-11-22
CH571528A5 (fr) 1976-01-15
IL30580A (en) 1975-05-22
BE719710A (fr) 1969-02-20
CH553817A (de) 1974-09-13
JPS5010873B1 (fr) 1975-04-24
FR1588246A (fr) 1970-04-10
CA946381A (en) 1974-04-30
SE386182B (sv) 1976-08-02
GB1241656A (en) 1971-08-04
IE32291L (en) 1969-02-21
AT306240B (de) 1973-03-26
NL159668B (nl) 1979-03-15
IE32291B1 (en) 1973-06-13
DE1795188B2 (de) 1979-03-29
US3665003A (en) 1972-05-23
AT301018B (de) 1972-08-25
US3790567A (en) 1974-02-05

Similar Documents

Publication Publication Date Title
AU425114B2 (fr)
AT298283B (fr)
AU416737B2 (fr)
AU342066A (fr)
AU610966A (fr)
BE692780A (fr)
BE692654A (fr)
BE711031A (fr)
BE710891A (fr)
BE710769A (fr)
BE710618A (fr)
BE710550A (fr)
BE710239A (fr)
BE709969A (fr)
BE709813A (fr)
BE709440A (fr)
BE692332A (fr)
BE709295A (fr)
BE708891A (fr)
BE708317A (fr)
BE708049A (fr)
BE704473A (fr)
BE702111A (fr)
BE709422A (fr)
BE692779A (fr)